CDC Giving $2 million To UN to ID & Track HIV+Africans

--------------------------------------------------------------------------------

Sometimes when the newsrooms lull us with their metronome stories, I out of sheer boredom go to the Federal Register to "follow the money" in an often frivolous effort to see what the media is so driven to NOT report. Today is one of those days. I found a CDC announcement in the Friday August 18th Federal Register stating that we are awarding the UN $2 million more to track with technology, not treat with retrovirus medication, persons in Africa who WHO infected with AIDS. The UN agency recipient will be determined based on the CDC's review of requested grant applications.

Just a thought... speaking of technology and identification/tracking, can you see the "value" in giving the HIV+ folks a Digital Angel implant to track them? I can imagine the grant proposal now... something like "Benefits: Persons without AIDS can easily identify sexual partners who may pose a risk, thereby bringing the spread to a total hault". You know, just like the yellow Star of David on the WWII Jews stopped the spread of their gaining support from the population at large?

--Data Junkie

Quote:
--------------------------------------------------------------------------------
Use of Funds

General Use
Funds may be used for strengthening the technical capacity of

national AIDS control programs, the purchase of drugs for primary
prevention (e.g., Sexually Transmitted Diseases (STD) and Tuberculosis
(TB) treatment, prevention of perinatal HIV transmission, and other
opportunistic infections related to AIDS illness) and for equipment,
supplies and reagents for rapid screening for HIV and STDs, and in
support of the delivery of HIV prevention and care and treatment
services.
General Non-Use
Funds received from this announcement will not be used for capital
expenditures such as the purchase of off-road and multi-passenger
vehicles, large volume (greater than 50) purchase of computers and data
storage systems, space renovations and other significant improvements
to physical environments where activities are carried out.
Specific Non-Use
Funds received from this announcement will not be used for the
direct purchase of antiretroviral drugs for treatment of established
HIV infection, occupational exposures, and non-occupational exposures
and will not be used for the direct purchase of equipment and reagents
to conduct hospital-based laboratory monitoring for patient care or
confirmatory tests.
--------------------------------------------------------------------------------